Search clinical trials for: pneumococcus conjugated vaccine

Total 10322 results

Assistance Publique - Hôpitaux de Paris

Unknown

Immunogenicity of a Combined Anti-pneumococcal Vaccine Schedule in Patients With ANCA-associated Vasculitis

ANCA-associated Vasculitis | Pneumococcal Infection

France
SK Chemicals Co., Ltd.

Completed

Study Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine

Pneumococcal Infections
Pfizer

Completed

Prevenar Special Use-result Surveillance in Japan (Regulatory PostMarketing Commitment Plan)

Streptococcus Pneumoniae | Pneumococcal Vaccine

Japan
Karolinska University Hospital

Completed

Pneumococcal Vaccine in Untreated CLL Patients

Chronic Lymphocytic Leukemia

Sweden
Mayo Clinic

Completed

Analysis of the Mechanisms of Protective Humoral Immunity in Response to the Pneumococcal Vaccine

Healthy

United States
Sanofi Pasteur, a Sanofi Company

Completed

Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination

Hepatitis B | Whooping Cough | Tetanus | Diphtheria | Poliomyelitis | Haemophilus Influenzae Type b

Colombia, Costa Rica
Genocea Biosciences, Inc.

Completed

Safety and Immunogenicity Study of Prophylactic Streptococcus Pneumoniae Vaccine

Streptococcus Pneumoniae

United States
Memorial Sloan Kettering Cancer Center

Completed

Prospective Trial of Vaccine Responses Against Pneumococcus and Influenza in Adult Cancer Patients 65 Years of Age and Older

Breast Cancer | Lung Cancer | Prostate Cancer

United States
University of Oxford
Mason Medical Research Trust

Completed

Pneumococcal Adult Kinetics Study - Understanding the B Cell Response to Pneumococcal Vaccines

Pneumococcal Disease

United Kingdom
University of Oxford

Completed

An Alternative Booster Vaccine Against Meningitis and Ear Infections

Invasive Streptococcus Pneumoniae Disease

United Kingdom
Korea University Guro Hospital

Completed

Influenza Vaccine and Pneumococcal Vaccine

Pneumococcal Infections | Influenza, Human

Korea, Republic of
Novartis Vaccines

Completed

Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study

Healthy

United Kingdom
Universitaire Ziekenhuizen KU Leuven
KU Leuven

Unknown

Polysaccharide Antibody Response Study (PARS)

Specific Polysaccharide Antibody Deficiency

Belgium
University of Florida

Completed

The Effect of Short-term Atorvastatin Treatment on Immune Responses to Pneumovax 23 (StatVax)

Healthy Controls

United States
University of Toledo Health Science Campus
National Institute on Aging (NIA)

Completed

Pneumonia Vaccine in Aging HIV Positive Individuals

Pneumococcal Infection

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Lenalidomide and Vaccine Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
University of Toledo Health Science Campus
National Institutes of Health (NIH)

Completed

Immune Response to Pneumococcal Vaccination in HIV Infected Individuals

Pneumococcal Infection

United States
Swiss Tropical & Public Health Institute
Swiss Academy of Medical Sciences (SAMS)

Completed

Benefit of a Single Preoperative Dose of Antibiotics for the Prevention of Surgical Site Infections (SSI2)

Surgical Site Infection

Switzerland
National Institute on Aging (NIA)

Completed

PPV: Pneumococcal Polysaccharide Vaccine in Older Adults

Aging

United States
AZ Sint-Jan AV
Pfizer

Completed

13 Valent Pneumococcal Conjugate Vaccine in Chronic Dialysis Patients

Chronic Kidney Failure

Belgium
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of a Booster Dose of Pneumo 23® in 12 to 18 Months-Old Children Primed With Prevnar

Streptococcus Pneumoniae

Thailand
Pfizer

Completed

Safety and Immunogenicity Study of MenC-TT Vaccine (NeisVac-C) in Toddlers Previously Immunized With PCV7 (Prevenar®)

Neisseria Meningitidis (Bacterial Meningitis) | Invasive Pneumococcal Disease (IPD)

Germany
Pfizer

Completed

NeisVac-C Single Prime Study in Infants

Neisseria Meningitidis

Poland, Spain
University of Minnesota
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Comparing Two Pneumococcal Vaccines in Adults With Chronic Obstructive Pulmonary Disease (PNEUMO)

Pulmonary Disease, Chronic Obstructive

United States
Children's National Research Institute
Pfizer

Completed

Comparison of Immunization Quality Improvement Dissemination Study (CIzQIDS)

Immunization | Hepatitis B Vaccine | Poliovirus Vaccine, Inactivated | DTaP Vaccine | MMR Vaccine | HIB-vaccine | Chickenpox Vaccine | Pneumococcal Polysaccharide Vaccine
Ferring Pharmaceuticals

Terminated

Daytime Impact Sleep Study (DAISS)

Nocturia

United Kingdom
McGill University Health Centre/Research Institute...
Merck Sharp & Dohme LLC

Withdrawn

Immune Responses in Patients Treated With Raltegravir (RAG-1/2)

HIV Infections

Canada
Pfizer

Completed

Study Evaluating 13 Valent Pneumococcal Conjugate Vaccine With Trivalent Inactivated Influenza Vaccine

Influenza

United States
St. Olavs Hospital

Terminated

Desmopressin as Treatment for Postoperative Bleeding After Cardiac Surgery

Hemorrhage | Postoperative Blood Loss

Norway
Korea University Guro Hospital
Pfizer

Completed

Immunogenicity and Safety of PCV13 and Fluad in Adults Aged ≥60 Years

Influenza | Streptococcus Pneumoniae

Korea, Republic of
Novartis Vaccines

Completed

Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered With or Without Routine Infant Vaccinations to Healthy Infants According to Different Immunization Schedules

Meningococcal Infections

Belgium, Czech Republic, Germany, Italy, Spain, United Kingdom
Sanofi Pasteur, a Sanofi Company

Completed

Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adults

Pneumococcal Infections | Streptococcus Pneumoniae Infections | Pneumococcal Pneumonia

Switzerland
Pfizer

Completed

13vPnC Multidose Vial Safety, Tolerability and Immunogenicity Study in Healthy Infants.

Pneumococcal Vaccines

Gambia
Emory University
Millennium Pharmaceuticals, Inc.; Ortho Biotech, Inc.

Completed

Protocol of the Combination of Bortezomib and Tipifarnib for Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

United States, Canada
National Institute of Allergy and Infectious Diseases...

Completed

Increasing HAART-Induced Immune Restoration With Cyclosporine

HIV Infections

United States
Statens Serum Institut
Hvidovre University Hospital; Herlev Hospital

Completed

Pneumococcal Vaccination of Crohn Patients (PneuVAC)

Crohns Disease

Denmark
Merck Sharp & Dohme LLC

Completed

A Study of V110 a Pneumococcal Vaccine in Healthy Adults (V110-013)

Healthy | Pneumococcal Infections
St. Antonius Hospital

Completed

Community Acquired Pneumonia: Outcome, Quality of Life and Immune Status (CAPolista)

Pneumonia | Immune Response | Streptococcus Pneumoniae

Netherlands
Pfizer

Completed

Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in HIV-Infected Subjects 6 Years of Age or Older Who Are Naive to Pneumococcal Vaccine

HIV Infections | Pneumococcal Infections

South Africa, Romania
Walvax Biotechnology Co., Ltd.
Air Force Military Medical University, China; Guangxi Center for Disease Control...

Completed

Safety and Immunogenicity of a Newly 23-valent Pneumococcal Polysaccharide Vaccine in Chinese Adults and Children

Pneumococcal Infectious Diseases

China
National Institute of Allergy and Infectious Diseases...

Completed

9-valent CRM 197 Pneumococcal

Pneumococcal Infection

United States
Kyunghee University Medical Center
Asan Medical Center; Seoul National University Hospital; Korea University; Chung-Ang... and other collaborators

Completed

Efficacy Study of Pneumococcal Vaccination in Crohn's Disease

Crohn's Disease

Korea, Republic of
Uniformed Services University of the Health Sciences
National Institute of Allergy and Infectious Diseases (NIAID); US Military... and other collaborators

Completed

Pneumococcal Conjugate Vaccination in HIV in Comparison to Polysaccharide Vaccine Boosting

HIV Infections | Streptococcus Pneumoniae

United States
Pfizer

Completed

Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults (CAPITA)

Pneumococcal Infections | Pneumonia, Pneumococcal | 13-valent Pneumococcal Vaccine

Netherlands
Korea University Guro Hospital
Novartis

Completed

MF59-adjuvanted Influenza Vaccine and 23-valent Pneumococcal Polysaccharide Vaccine

Pneumococcal Infections | Influenza, Human
Pfizer

Completed

A Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) In Healthy Infants In China

Pneumococcal Infection

China
Sanofi Pasteur, a Sanofi Company

Completed

Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy Infants

Hepatitis B | Whooping Cough | Tetanus | Diphtheria | Poliomyelitis

Colombia, Costa Rica
Pfizer
Kaiser Permanente

Completed

Postlicensure Observational Safety Study of 13vPnC Administered to Infants and Toddlers

Pneumococcal Disease

United States
Menzies School of Health Research
National Health and Medical Research Council, Australia

Completed

PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers (PneuMum)

Pneumococcal Infections | Tympanic Membrane Perforation | Acute Otitis Media | Middle Ear Effusion

Australia
International Centre for Diarrhoeal Disease Research...
Sanofi Pasteur, a Sanofi Company

Completed

Pneumococcal Protein Vaccine Safety and Immunogenicity Trial (PPR02)

Adverse Effects

Bangladesh

Search clinical trials for: pneumococcus conjugated vaccine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mali

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations